- Display 30 Products per page
Published: October 1, 2006 | Price: $1,200.00 – $5,990.00
Ultrasound, also known as sonography, is not a new imaging modality—having been around since the 1950s—but its application areas have just recently begun to expand tremendously. These new clinical applications, along with technological innovations in portability and resolution and a very favorable risk profile, have made ultrasound equipment a very robust market sector. This third volume in Kalorama’s ongoing series on medical imaging examines the market for ultrasound equipment worldwide, reviewing the drivers and restraints, the established and emerging application...Published: February 1, 2007 | Price: $1,995.00 – $5,990.00
Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...Published: May 1, 2007 | Price: $2,995.00 – $5,990.00
Molecular imaging maps the locations of specific molecules and biomaterials within living tissue. As such, it has the potential to diagnose a disease, to monitor the course of that disease, and possibly facilitate treatment. Molecular imaging has developed into a promising new strategy for the diagnosis, evaluation and treatment of disease. The final volume in Kalorama's Medical Imaging Markets series: Medical Imaging Markets, Volume V, Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the...Published: November 1, 2009 | Price: $3,500.00 – $7,000.00
The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets. Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of...Published: July 9, 2012 | Price: $3,995.00 – $7,990.00
Today’s capabilities in clinical diagnostic radiology have been made possible by advances not only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it possible to see, in great detail, the body’s internal structures, organs and tissue that would nototherwise be clearly seen. Although bones are readily apparent on radiographic images, other organs and tissues are not. These imaging agents may be usedduring a medical imaging procedure to highlight specific parts of the body andmake them...Published: July 1, 2010 | Price: $3,500.00 – $7,000.00
Molecular imaging involves the ability to generate images of specific molecules within the body. The versatility of medical imaging modalities is continuing to increase as care givers keep older people alive longer. Age-related diseases such as cancer, stroke and heart disease represent the highest cost burden to health care in developed countries. Kalorama Information has been noting developments in these technologies and rendering the market for them visible to market watchers and business planners. Medical Imaging Markets: Molecular Imaging offers...Published: September 26, 2012 | Price: $3,995.00 – $7,990.00
Molecular imaging techniques include nuclear medicine imaging – positron emission tomography (PET) and single photon emission computed tomography (SPECT) and combination PET/CT and SPECT/CT techniques – as well as ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) imaging that are used with molecular imaging agents. Molecular imaging has evolved into a pillar of molecular medicine. It combines functional imaging with structural imaging so that specific in-vivo molecular processes can be identified and spatially pinpointed, often with the use of...Published: August 1, 2009 | Price: $3,500.00 – $7,000.00
This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI. the report includes the following as part of its market coverage: Current Market Size and Forecast for MRI Systems Market Size and Forecasts for MRI Procedures Installed Base of MRI Systems (Open, Closed, Low to Mid Field, High...Published: March 1, 2012 | Price: $3,500.00 – $7,000.00
This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI. the report includes the following as part of its market coverage: Current Market Size and Forecast for MRI Systems Installed Base of MRI Systems (Open, Closed, Low to Mid Field, High Field) Estimated Cost of MRI Systems...Published: November 1, 2011 | Price: $150.00 – $300.00
Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurance companies and the aging of the population are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from Kalorama Information, details these factors and provides 2011 market size and forecast to 2015 for...Published: February 17, 2015 | Price: $500.00 – $1,000.00
IVD Mergers and Acquisitions Kalorama Information continously tracks mergers and acquisitons in the IVD market. This report IVD Mergers and Acquisitions, records and details 130 significant acquisitions that have taken place from 2012 to early 2015. Companies are the future of the industry lies in the development of more accurate, faster, usable devices. It also involves devices that are IT capable. It’s impossible for eve the largest companies to own all of the innovative technology, so M&A is an important...Published: January 10, 2017 | Price: $796.00 – $1,592.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.Published: March 27, 2018 | Price: $995.00 – $1,990.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018. Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures...Published: June 28, 2019 | Price: $2,000.00 – $4,000.00
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: July 25, 2017 | Price: $2,800.00 – $5,600.00
Mexico IVD Market Analysis In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue data on the major market sub-segments for 2016-2021: In Vitro Diagnostic Sales by Market Segment (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose,...Published: February 12, 2020 | Price: $5,500.00 – $11,000.00
The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular diagnostics. PCR is the initial step used in isolating and amplifying specific regions of...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...Published: October 1, 2004 | Price: $995.00 – $1,990.00
The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic constitution. Differences in drug metabolism may lead to varying adverse events or more pronounced adverse events in different individuals, and differing metabolism may also lead...Published: November 29, 2023 | Price: $5,000.00 – $10,000.00
In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare. For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost. While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...Published: July 9, 2020 | Price: $5,500.00 – $11,000.00
Molecular Diagnostics could be said to be the most important part of in vitro diagnostics. This is especially true in the wake of COVID-19. Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be a year of growth and...Published: May 5, 2022 | Price: $10,000.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel...Published: April 24, 2024 | Price: $10,500.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...Published: June 1, 2005 | Price: $995.00 – $1,990.00
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...Published: July 23, 2019 | Price: $4,500.00 – $9,000.00
Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several segments where testing at the molecular level has thrived, including the following: • HPV Testing • CT/NG Testing • Molecular Hepatitis Testing • HIV Testing...Published: November 24, 2014 | Price: $995.00 – $1,990.00
MRI: World Market Analysis Medical imaging has led to improvements in the diagnosis and treatment of numerous medical conditions in children and adults. There are many types of medical imaging procedures, each of which uses different technologies and techniques. MRI is a noninvasive medical diagnostic technique that uses a magnetic field and radio waves to create detailed images of the organs and tissues within the body. MRI machines are used to produce cross-sectional MRI images and three-dimensional images that may...Published: February 5, 2016 | Price: $2,000.00 – $4,000.00
Novel Autism Diagnostics Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put on the back burner due to technical difficulties. The six...Published: April 12, 2017 | Price: $3,196.00 – $6,392.00
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and...